Seven months ago, the Health and Care Act 2022 gave ministers the power to create a licensing regime for non-surgical cosmetic procedures in England. As of this week, parts of that regime are live.
If you run an aesthetics clinic, the next few months will test whether your compliance paperwork is actually fit for purpose or just reassuringly thick.
Here is what has changed, what is still being confirmed, and what you should do before the summer rush gets in the way.
What the licensing scheme actually covers
The tiered licensing scheme applies to procedures carried out in England. Scotland, Wales, and Northern Ireland have their own regulatory arrangements, so if you operate across borders, you will need to check each jurisdiction separately.
The scheme divides procedures into two broad groups. The first covers treatments that can only be performed by a regulated healthcare professional, a doctor, nurse, dentist, or pharmacist with the appropriate prescribing credentials. Injectable botulinum toxin and dermal fillers sit here. The second tier covers treatments that require a licence but can be performed by trained practitioners who are not registered healthcare professionals, provided certain conditions are met.
The July 2026 changes tighten the rules around injectable supply chains. From this month, aesthetic practitioners who are not independent prescribers cannot legally obtain prescription-only medicines for cosmetic use through a "prescribe and supply" arrangement with a remote prescriber who has never assessed the patient in person. The patient must have had a face-to-face consultation with the prescribing clinician. That is a real change, and it closes a route that a significant number of smaller independent clinics have been relying on.
This is not a gentle nudge. The JCCP (Joint Council for Cosmetic Practitioners) has been flagging since 2024 that enforcement would follow implementation. Councils and health bodies can now refer non-compliant practitioners.
The tiered licensing scheme and what "licence" actually means
There has been a lot of confusion in practitioner forums about whether you need a new licence on top of existing registrations. The short answer is: it depends on what you do.
If you are performing procedures in the higher-risk category, the relevant licensing authority needs to be satisfied that the practitioner is appropriately qualified and that the clinic premises meet the required standards. For CQC-registered clinics, some of this overlaps with existing registration requirements. But CQC registration is not a substitute for the cosmetic procedure licence, and the two systems are currently running in parallel without a clean handover point.
The Local Authority is the licensing authority for the lower-tier procedures. Your local council issues or refuses those licences, and the application process varies considerably between authorities. Several councils had not published their processes as of late June 2026, which is not ideal for anyone trying to comply in good faith.
If you are not sure which tier applies to each procedure you offer, the JCCP published a procedure classification list in March 2026. That is the most practical reference document available right now.
The supply chain problem is the most urgent thing
Aesthetics practitioners who are not independent prescribers need to sort out their prescribing arrangements now, not in August.
The ban on remote prescribing for cosmetic injectables without a prior in-person assessment means that any arrangement where a remote GP or nurse prescriber was signing off treatments based on a patient questionnaire and photos is no longer compliant. Full stop.
Your options are to employ or contract with an independent prescriber who sees patients in person at your clinic, to have patients attend a face-to-face consultation with an appropriate prescriber before treatment, or to stop offering those treatments.
Some clinic owners have asked whether a video consultation counts as "in person." Current guidance says it does not for this specific purpose. If that position changes, the ICO or MHRA will update the relevant guidance, but for now, assume video is not sufficient.
This is the area where I have seen the most wishful thinking in the forums. "We've always done it this way" is not a compliance argument. The supply chain rules have teeth.
What to actually do this week
Check your current prescribing arrangements before you book another injectable appointment. If a remote prescriber has been signing off treatments without an in-person assessment, you need to stop that arrangement immediately and find an alternative.
Pull out your procedure list and cross-reference it against the JCCP classification published in March 2026. For every procedure that sits in the higher-risk tier, confirm who in your team is qualified to perform it and whether that person's registration is current.
Contact your local council about the lower-tier licensing process. Even if they haven't published a formal application process yet, getting your name on their radar and understanding the timeline will save you scrambling later.
Review your consent and record-keeping processes. The new scheme expects documentation that demonstrates patient assessment, practitioner competency, and informed consent as a linked sequence, not three separate boxes to tick. HealSuite's consultation and consent workflows are built to produce that kind of linked audit trail, which is worth knowing if you are rebuilding your forms.
Check your insurance. Several medical malpractice and professional indemnity insurers have updated their policy wording to exclude treatments performed outside the new licensing requirements. A claim made on a treatment delivered without the proper licence in place may not pay out.
The honest part
I will say plainly that the rollout has been messy. The government published the framework, but local authorities have been left to implement it with very uneven preparation. Some practitioners in London have had licence applications acknowledged and processed quickly. Others in smaller towns have been told the council "is looking into it." That is not a situation that inspires confidence.
What that means practically is that good-faith compliance efforts need to be documented even when the authority at the other end is not organised. Keep a record of when you applied, who you spoke to, what you were told. If enforcement action is ever taken, being able to show you made genuine attempts to comply will matter.
The AATT (Association of Aesthetic Training and Therapy) has a template letter you can send to councils that have not yet published their process. Use it.
The scheme is not finished. Guidance documents are still being updated, and there are at least two pending consultations on procedure classifications that could shift where specific treatments sit in the tiering. Sign up for the JCCP newsletter if you are not already on it. Right now it is the most reliable way to stay current without spending hours on GOV.UK hoping the right page has been updated.